{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:53:26Z","timestamp":1772549606861,"version":"3.50.1"},"reference-count":39,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.5551\/jat.63265","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T22:08:51Z","timestamp":1641679731000},"page":"1646-1654","source":"Crossref","is-referenced-by-count":3,"title":["Statin Use Influence on the Occurrence of Acute Kidney Injury in Patients with Peripheral Arterial Disease"],"prefix":"10.5551","volume":"29","author":[{"given":"Daisuke","family":"Kanai","sequence":"first","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"},{"name":"Department of Nephrology and Kidney Center, Kakogawa Central City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Center, Kakogawa Central City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Heung M, Chawla LS. Acute kidney injury: gateway to chronic kidney disease. Nephron Clin Pract, 2014; 127: 30-34","DOI":"10.1159\/000363675"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med, 2014; 371: 58-66","DOI":"10.1056\/NEJMra1214243"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) McCullough PA, Wolyn R, Rocher LL, Levin RN, O\u2019Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med, 1997; 103: 368-375","DOI":"10.1016\/S0002-9343(97)00150-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lameire N, Adam A, Becker CR, Davidson C, McCullough PA, Stacul F, Tumlin J, CIN Consensus Working Panel. Baseline renal function screening. Am J Cardiol, 2006; 98: 21K-26K","DOI":"10.1016\/j.amjcard.2006.01.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) La Manna G, Pancaldi LG, Capecchi A, Maska E, Comai G, Cappuccilli ML, Carretta E, Lombardi A, Coli L, Stefoni S. Risk for contrast nephropathy in patients undergoing coronarography. Artif Organs, 2010; 34: E193-199","DOI":"10.1111\/j.1525-1594.2009.00984.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Solomon R, Werner C, Mann D, D\u2019Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med, 1994; 331: 1416-1420","DOI":"10.1056\/NEJM199411243312104"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totune K, Hoshi H, Ito S, Imai Y. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study. Nephrol Dial Transplant, 2007; 22: 1910-1915","DOI":"10.1093\/ndt\/gfm051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003; 41: 47-55","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jurado-Rom\u00e1n A, Hern\u00e1ndez-Hern\u00e1ndez F, Garc\u00eda-Tejada J, Granda-Nistal C, Molina J, Vel\u00e1zquez M, Albarr\u00e1n A, Tasc\u00f3n J. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol, 2015; 115: 1174-1178","DOI":"10.1016\/j.amjcard.2015.02.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract, 2012; 120: c179-184","DOI":"10.1159\/000339789"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC\/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation, 2006; 113: e463-654","DOI":"10.1161\/CIRCULATIONAHA.106.173994"},{"key":"12","unstructured":"12) Kodzwa R. Acr manual on contrast media: 2018 updates. Radiol Technol, 2019; 91: 97-100"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Singh N, Lee JZ, Huang JJ, Low SW, Howe C, Pandit A, Suryanarayana P, Lee KS. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart, 2014; 1: e000127","DOI":"10.1136\/openhrt-2014-000127"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sun Y-Y, Liu L-Y, Sun T, Wu M-Y, Ma F-Z. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data. Clin Nephrol, 2019; 92: 123-130","DOI":"10.5414\/CN109497"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang N, Qian P, Yan TD, Phan K. Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: A systematic review and trial sequential analysis. Int J Cardiol, 2016; 206: 143-152","DOI":"10.1016\/j.ijcard.2016.01.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Liew YP, Bartholomew JR, Demirjian S, Michaels J, Schreiber MJ. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol, 2008; 3: 1084-1089","DOI":"10.2215\/CJN.04411007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Adam DJ, Bradbury AW. TASC II document on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg, 2007; 33: 1-2","DOI":"10.1016\/j.ejvs.2006.11.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kang Y-P, Chen L-Y, Kang T-D, Liu W-X. Clinical characteristics and adverse events in acute coronary syndrome patients with a history of peripheral arterial disease. Arq Bras Cardiol, 2019; 113: 367-372","DOI":"10.5935\/abc.20190150"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation, 2004; 109: 733-739","DOI":"10.1161\/01.CIR.0000112642.63927.54"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ankle Brachial Index Collaboration; Fowkes FGR, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FGR, Lee AJ, Price JF, d&apos;Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodr\u00edguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CDA, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MMB, Hunink MGM, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, HammanR, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA, 2008; 300: 197-208","DOI":"10.1001\/jama.300.2.197"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med, 1992; 326: 381-386","DOI":"10.1056\/NEJM199202063260605"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AYJ, Jorgensen M, Dua A, Short L, Kane K. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet, 2014; 383: 1814-1823","DOI":"10.1016\/S0140-6736(14)60689-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A, Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol, 2003; 42: 211-216","DOI":"10.1016\/S0735-1097(03)00579-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shacham Y, Leshem-Rubinow E, Gal-Oz A, Arbel Y, Keren G, Roth A, Steinvil A. Acute cardio-renal syndrome as a cause for renal deterioration among myocardial infarction patients treated with primary percutaneous intervention. Can J Cardiol, 2015; 31: 1240-1244","DOI":"10.1016\/j.cjca.2015.03.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Narula A, Mehran R, Weisz G, Dangas GD, Yu J, G\u00e9n\u00e9reux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G, Clark AE, Fahy M, Xu K, Brodie BR, Stone GW. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J, 2014; 35: 1533-1540","DOI":"10.1093\/eurheartj\/ehu063"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, Noma S, Kawamura A, Kohsaka S, Fukuda K. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol, 2013; 62: 1260-1266","DOI":"10.1016\/j.jacc.2013.03.086"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sendeski M, Patzak A, Pallone TL, Cao C, Persson AE, Persson PB. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology, 2009; 251: 697-704","DOI":"10.1148\/radiol.2513081732"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Liu ZZ, Schmerbach K, Lu Y, Perlewitz A, Nikitina T, Cantow K, Seeliger E, Persson PB, Patzak A, Liu R, Sendeski MM. Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback. Am J Physiol Renal Physiol, 2014; 306: F864-872","DOI":"10.1152\/ajprenal.00302.2013"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ribeiro L, de Assun\u00e7\u00e3o e Silva F, Kurihara RS, Schor N, Mieko E, Higa S. Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents. Kidney Int, 2004; 65: 589-596","DOI":"10.1111\/j.1523-1755.2004.00408.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Pisani A, Riccio E, Andreucci M, Faga T, Ashour M, Nuzzi AD, Mancini A, Sabbatini M. Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy. Biomed Res Int, 2013; 2013: 868321","DOI":"10.1155\/2013\/868321"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nyman U, Bj\u00f6rk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol, 2008; 49: 658-667","DOI":"10.1080\/02841850802050762"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O&apos;Connor GT, Solomon RJ, Malenka DJ. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv, 2010; 3: 346-350","DOI":"10.1161\/CIRCINTERVENTIONS.109.910638"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med, 2012; 157: 251-262","DOI":"10.7326\/0003-4819-157-4-201208210-00005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, Tziomalos K, Ganotakis ES, Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (Greace) Study. Nephrol Dial Transplant, 2007; 22: 118-127","DOI":"10.1093\/ndt\/gfl538"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Scolari F, Ravani P, Gaggi R, Santostefano M, Rollino C, Stabellini N, Colla L, Viola BF, Maiorca P, Venturelli C, Bonardelli S, Faggiano P, Barrett BJ. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation, 2007; 116: 298-304","DOI":"10.1161\/CIRCULATIONAHA.106.680991"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Cho Aj, Lee Y-K, Sohn SY. Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis. Medicine (Baltimore), 2020; 99: e19473","DOI":"10.1097\/MD.0000000000019473"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Li H, Wang C, Liu C, Li R, Zou M, Cheng G. Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography\/percutaneous coronary intervention: a meta-analysis of 21 randomized controlled trials. Am J Cardiovasc Drugs, 2016; 16: 201-219","DOI":"10.1007\/s40256-016-0164-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Giacoppo D, Gargiulo G, Buccheri S, Aruta P, Byrne RA, Cassese S, Dangas G, Kastrati A, Mehran R, Tamburino C, Capodanno D. Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: evidence from a hierarchical bayesian network meta-analysis of 124 trials and 28 240 patients. Circ Cardiovasc Interv, 2017; 10: e004383","DOI":"10.1161\/CIRCINTERVENTIONS.116.004383"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature. Catheter Cardiovasc Interv, 2016; 88: 264-273","DOI":"10.1002\/ccd.26466"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/11\/29_63265\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:49:06Z","timestamp":1715316546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/11\/29_63265\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63265","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"63265"}}